Related Experiment Video
Updated: Jan 30, 2026

Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers
Published on: September 19, 2022
Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer
Daniel Shae1, Kyle W Becker1, Plamen Christov2
1Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA.
Abstract:
Cyclic dinucleotide (CDN) agonists of stimulator of interferon genes (STING) are a promising class of immunotherapeutics that activate innate immunity to increase tumour immunogenicity. However, the efficacy of CDNs is limited by drug delivery barriers, including poor cellular targeting, rapid clearance and inefficient transport to the cytosol where STING is localized. Here, we describe STING-activating nanoparticles (STING-NPs)-rationally designed polymersomes for enhanced cytosolic delivery of the endogenous CDN ligand for STING, 2'3' cyclic guanosine monophosphate-adenosine monophosphate (cGAMP). STING-NPs increase the biological potency of cGAMP, enhance STING signalling in the tumour microenvironment and sentinel lymph node, and convert immunosuppressive tumours to immunogenic, tumoricidal microenvironments. This leads to enhanced therapeutic efficacy of cGAMP, inhibition of tumour growth, increased rates of long-term survival, improved response to immune checkpoint blockade and induction of immunological memory that protects against tumour rechallenge. We validate STING-NPs in freshly isolated human melanoma tissue, highlighting their potential to improve clinical outcomes of immunotherapy.
Insights
Novel STING-activating nanoparticles (STING-NPs) improve the delivery of cyclic dinucleotides (CDNs) like cGAMP. These nanoparticles enhance anti-tumour immunity and therapeutic outcomes in preclinical models.
Area of Science:
- Immunology
- Nanotechnology
- Drug Delivery
Background:
- Cyclic dinucleotide (CDN) agonists targeting stimulator of interferon genes (STING) show promise as immunotherapeutics.
- Current CDN efficacy is limited by poor cellular delivery and rapid clearance, hindering STING activation in the cytosol.
Purpose of the Study:
- To develop rationally designed polymersomes, termed STING-activating nanoparticles (STING-NPs), for enhanced cytosolic delivery of 2'3' cyclic guanosine monophosphate-adenosine monophosphate (cGAMP).
- To evaluate the therapeutic potential of STING-NPs in converting immunosuppressive tumors into immunogenic, tumoricidal microenvironments.
Main Methods:
- STING-NPs were engineered as polymersomes encapsulating the endogenous STING ligand, cGAMP.
- The biological potency, STING signaling, and anti-tumor effects of STING-NPs were assessed in preclinical models.
- Efficacy was evaluated in freshly isolated human melanoma tissue.
Main Results:
- STING-NPs significantly enhanced the biological potency of cGAMP and improved STING signaling in the tumor microenvironment and sentinel lymph nodes.
- Treatment with STING-NPs converted immunosuppressive tumors to immunogenic, tumoricidal microenvironments, inhibiting tumor growth.
- STING-NPs improved responses to immune checkpoint blockade, induced long-term survival, and generated protective immunological memory.
Conclusions:
- STING-NPs represent a promising nanotechnology for improving CDN delivery and enhancing cancer immunotherapy.
- These nanoparticles demonstrate potential for improving clinical outcomes in cancer patients, including those with melanoma.
Related Concept Videos
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Tumor Immunotherapy
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Increasing Function
Stereoisomerism of Cyclic Compounds

